CMXC Projected Dividend Yield

Cell MedX Corp ( OTCBB : CMXC )

Cell MedX is a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to: diabetes, Parkinson's disease, high blood pressure, neuropathy and kidney function. Co.'s subsidiary, Cell MedX (Canada) Corp., is engaged in development and manufacturing of therapeutic devices based on Co.'s proprietary eBalance® Technology, which harnesses power of microcurrents and their effects on human body. eBalance Technology is based on the science of bioelectric signals, their effect on epigenetic events within human body.

20 YEAR PERFORMANCE RESULTS